As research continues, those involved say this would be a game changer, especially for patients with very limited options.

"Overall, metabolic responses to glucagon stimulation in individuals with type 1 diabetes are comparable to those in healthy ...

BioArctic AB (publ) (NASDAQ STOCKHOLM: BIOA B) today announced that the U.S. Food and Drug Administration (FDA) has approved BioArctic's partner Eisai's ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

A Wicklow mother is among a concerned group of parents who are calling for individual trials of the modulator therapies for their children with Cystic Fibrosis who still do not have access to these ...

BRAF V600E-mutant metastatic colorectal cancer (CRC) was associated with poor clinical outcomes in patients receiving ...

Scientists reveal groundbreaking discoveries about probiotics and acne treatment. Learn how these tiny organisms could ...

The compound was discovered and initially developed by Stony Brook University’s Iwao Ojima, PhD, and Martin Kaczocha, PhD.

Despite long COVID’s vast reach, and more than $1 billion spent on research, no new treatments have been brought to market.

In the pursuit of weight loss, individuals often find themselves overwhelmed by countless products and methods that promise ...

Having ADHD is associated with a shorter life expectancy and a greater risk of mental health issues, according to a new study ...

About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...